Publication | Closed Access

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

Methylprednisolone Versus MethylprednisoloneEndocrine DiseaseMedicineClinical TrialsMulticentre TrialThyroid HormonePharmacologyModerate-to-severe Graves